Recent Posts
- Philochem AG (a company of the Philogen group) announces the completion of central radiolabeling activities for the therapeutic use of OncoFAP-23
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
- Philogen announces new publication in Nature Chemistry
- Philochem to attend the 71st American Society for Mass Spectrometry Conference on June 4-8, 2023
- Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
Recent Comments